EP Wealth Advisors LLC Purchases New Stake in ICU Medical, Inc. (NASDAQ:ICUI)

EP Wealth Advisors LLC acquired a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 1,354 shares of the medical instruments supplier’s stock, valued at approximately $247,000.

A number of other institutional investors have also recently bought and sold shares of ICUI. Hexagon Capital Partners LLC increased its holdings in shares of ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP increased its stake in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares during the period. Innealta Capital LLC purchased a new stake in ICU Medical in the 2nd quarter worth approximately $32,000. Venturi Wealth Management LLC boosted its stake in shares of ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 302 shares during the period. Finally, Point72 Hong Kong Ltd purchased a new position in shares of ICU Medical during the 3rd quarter valued at $72,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Christian B. Voigtlander sold 1,430 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total value of $225,940.00. The disclosure for this sale can be found here. Insiders have sold a total of 40,364 shares of company stock worth $6,869,878 over the last 90 days. Insiders own 6.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ICUI. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp lifted their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, Raymond James increased their price target on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, ICU Medical has a consensus rating of “Moderate Buy” and an average target price of $177.25.

ICU Medical Stock Down 2.4 %

Shares of ICUI stock opened at $161.64 on Friday. The stock’s 50 day simple moving average is $171.12 and its 200 day simple moving average is $150.98. ICU Medical, Inc. has a twelve month low of $86.80 and a twelve month high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market capitalization of $3.96 billion, a price-to-earnings ratio of -35.37 and a beta of 0.62.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.